A Randomized Open Clinical Study of the Atherosclerosis Treatment Information Video Effect on Adherence to Long-Term Therapy in Patients with Cardiovascular Diseases

QR Code

A Randomized Open Clinical Study of the Atherosclerosis Treatment Information Video Effect on Adherence to Long-Term Therapy in Patients with Cardiovascular Diseases

Aim. Study the effect of a study video, which was created by researchers and devoted to the atherosclerosis development and the effect of statin therapy on atherosclerotic plaque, on adherence to long-term therapy in patients with high or very high risk of cardiovascular complications.Material and m...

Full description

Saved in:

Bibliographic Details
Main Authors:	Yu. V. Bulaeva, E. A. Naumova, O. N. Semenova, T. V. Kanaeva, K. A. Popov, А. R. Tyapayeva
Format:	Article
Language:	English
Published:	Столичная издательская компания 2021-11-01
Series:	Рациональная фармакотерапия в кардиологии
Subjects:	cardiovascular disease adherence statins educational video cholesterol
Online Access:	https://www.rpcardio.online/jour/article/view/2577
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Effectiveness of patient-oriented intervention in primary prevention of cardiovascular diseases with statins: Open-label randomized study
by: Elena Bochkareva, et al.
Published: (2025-06-01)

APPROACHES TO STATIN THERAPY ADHERENCE IMPROVEMENT
by: S. A. Shalnova, et al.
Published: (2018-04-01)

Adherence to statin therapy in patients with high and very high cardiovascular risk in real clinical practice
by: V. I. Podzolkov, et al.
Published: (2020-03-01)

Studying the Possibility of Optimizing the Statin Therapy Algorithm in Outpatient Practice
by: D. V. Nebieridze, et al.
Published: (2020-09-01)

EFFECT OF SIMVASTATIN ON MARKERS OF CARDIOVASCULAR RISK
by: N. V. Perova, et al.
Published: (2016-01-01)

Adherence to Statins Therapy of High and Very High Cardiovascular Risk Patients in Real Clinical Practice: Diagnostics and Possible Ways to Solve the Problem (According to the PRIORITY Observational Study)
by: S. Yu. Martsevich, et al.
Published: (2019-01-01)

Challenges in managing adherence in patients with cardiovascular disease (review)
by: Yu. S. Ignatova, et al.
Published: (2025-01-01)

Conundrum of Cholesterol Management and Health Implications of Low Cholesterol Levels: A Narrative Review
by: Subodh Bashyal, et al.
Published: (2025-07-01)

STUDY OF ADHERENCE TO DRUG THERAPY OF PATIENTS WITH CARDIOVASCULAR DISEASES IN DISTRICT HOSPITAL OF SMALL TOWN IN SARATOV REGION AND IN CARDIOLOGY DEPARTMENT OF UNIVERSITY CLINIC IN SARATOV
by: Yu. V. Bulaeva, et al.
Published: (2018-07-01)

Statin therapy and atherosclerosis regression
by: A. V. Susekov
Published: (1970-01-01)

Double cholesterol inhibition — a new approach to effective control of hyperlipidemia and atherosclerosis
by: A. V. Susekov, et al.
Published: (2009-12-01)

Atherosclerosis pathogenesis from the perspective of microvascular dysfunction
by: D. M. Aronov, et al.
Published: (2021-11-01)

TREATMENT ADHERENCE AS AN ESSENTIAL ELEMENT OF CARDIOVASCULAR DISORDERS MANAGEMENT
by: D. V. Nebieridze, et al.
Published: (2017-12-01)

ADHERENCE TO LONG-TERM TREATMENT OF CARDIOVASCULAR DISEASE AND NON-COMPLIANCE WITH MEDICAL RECOMMENDATIONS: THE OPINION OF PATIENTS AND PHYSICIANS BY THE RESULTS OF FOCUSED INTERVIEW
by: O. N. Semenova, et al.
Published: (2015-09-01)

ACHIEVEMENT OF LIPID TARGET PLASMA LEVELS IN PATIENTS OF HIGH CARDIOVASCULAR RISK: IS MEDICINE CHOICE IMPORTANT?
by: S. Y. Martsevich, et al.
Published: (2016-01-01)

ANALYSIS OF HYPERCHOLESTEROLEMIA PREVALENCE IN THE OUTPATIENT PRACTICE (ACCORDING TO THE ARGO STUDY): PART I
by: N. M. Akhmedzhanov, et al.
Published: (2015-09-01)

The role of dyslipidemia and gender-related risk factors in the management of patients with abdominal aortic aneurysms: a survey from the Italian Society of Angiology and Vascular Medicine and a call to action
by: Martina Berteotti, et al.
Published: (2025-06-01)

PRIMARY PREVENTION OF CARDIOVASCULAR COMPLICATIONS: VALUE OF STATINS
by: S. Y. Martsevich, et al.
Published: (2016-01-01)

RHEUMATOID ARTHRITIS AND CARDIOVASCULAR RISK: PERSPECTIVES OF TREATMENT WITH STATINS
by: D. A. Anichkov, et al.
Published: (2015-12-01)

Medication adherence of cardiovascular patients after COVID-19: 6-month follow-up
by: A. R. Tyapaeva, et al.
Published: (2024-04-01)

Efficacy and safety of statin therapy in multimorbid outpatients with very high cardiovascular risk
by: N. V. Izmozherova, et al.
Published: (2020-07-01)

Medication Adherence: does Patient Participation in Randomized Clinical Trials Affect on it?
by: N. O. Vasyukova, et al.
Published: (2019-07-01)

Serum lipids and smoking status in coronary heart disease patients treated with simvastatin
by: L. R. Gazdanova, et al.
Published: (2010-04-01)

Hypolipidemic effectiveness and safety of generic lovastatin
by: D. M. Aronov, et al.
Published: (2006-12-01)

Biochemical, structural and clinical analysis of statins’ pleiotropic effects
by: A. N. Britov, et al.
Published: (2009-10-01)

Assessment of adherence to medication and visits in healthcare facilities for cardiovascular patients who participated in international randomized controlled trials
by: N. O. Vasyukova, et al.
Published: (2019-12-01)

UP TO DATE STATINS IN PRIMARY AND SECONDARY PREVENTION OF CARDIOVASCULAR DISEASES
by: N. F. Puchin'yan, et al.
Published: (2015-12-01)

ADHERENCE TO TREATMENT AND QUALITY OF LIFE OF PATIENTS WITH CARDIOVASCULAR DISEASES AT THE OUTPATIENT TREATMENT STAGE OF MEDICAL CARE
by: E. A. Kuzheleva, et al.
Published: (2020-06-01)

Adherence to Clinical Quidelines on Preoperative Assessment and Correction of Cardiovascular Risk in Non-cardiac Surgery
by: M. D. Nigmatkulova, et al.
Published: (2020-12-01)

Simultaneous inhibition of cholesterol absorption and synthesis in combined therapy with ezetimibe and simvastatin
by: D. M. Aronov
Published: (2005-08-01)

Hyperlipidemia and gut microbiota: the role of prebiotics, probiotics, statins and fibrates
by: I. N. Grigor’eva, et al.
Published: (2025-07-01)

CORRECTION OF DYSLIPIDEMIA: HISTORICAL ASPECT AND CURRENT VIEW OF THE PROBLEM (REVIEW, PART IІ)
by: Dmytro D. Diachuk, et al.
Published: (2025-04-01)

Patients with Premature Cardiovascular Diseases in Ambulatory Practice: Demographic Characteristics, Risk Factors and Adherence to the Medical Therapy (Data of RECVASA Registry)
by: E. Yu. Andreenkо, et al.
Published: (2020-05-01)

The place of original pitavastatin in primary and secondary prevention of cardiovascular diseases. Interdisciplinary Expert Consensus of the Russian Society of Cardiology, the National Atherosclerosis Society, the Russian Society of Cardiosomatic Rehabilitation and Secondary Prevention, and the Russian Association of Endocrinologists
by: Marina G. Bubnova, et al.
Published: (2025-01-01)

Video Equipment and Video Shot Composition
by: Ricky Telg, et al.
Published: (2021-07-01)

LIFE QUALITY, PSYCHOLOGICAL STATE, TREATMENT AND PREVENTION ADHERENCE EVALUATION IN LOCAL POLYCLINIC PATIENTS
by: E. V. Indukaeva, et al.
Published: (2017-08-01)

Interactions between gut microbiota and cardiovascular drugs: effects on drug therapeutic effect and side effect
by: Tianyu Wang, et al.
Published: (2025-07-01)

Lipid-lowering therapy: modern possibilities and real clinical practice
by: A. V. Blokhina, et al.
Published: (2022-09-01)

Molecular pharmacology of coenzyme Q10 in the context of treatment of hyperlipidemic conditions
by: O. A. Gromova, et al.
Published: (2023-07-01)

A randomized controlled trial of statin therapy effect on androgen status and erectile function in men with high and very high cardiovascular risk (TRISTAN): rationale and study protocol
by: K. P. Raevskii, et al.
Published: (2025-06-01)